BUYB targets companies that have consistently reduced their share count through buybacks, betting that firms returning cash this way tend to outperform. It's essentially a quality screen disguised as a buyback strategy, since only profitable companies with excess capital can sustain multi-year repurchase programs.
How It Works
The fund tracks an index of S&P 500 companies that have reduced shares outstanding by at least 5% annually for seven consecutive years — a remarkably high bar that typically yields 20-40 holdings. Equal-weighted and rebalanced quarterly, it concentrates in sectors like financials and tech where buybacks are cultural. The seven-year requirement means you're getting battle-tested capital allocators, not one-time repurchasers trying to prop up earnings.
Key Features
- Extreme selectivity — only ~5-8% of S&P 500 companies qualify for this stringent buyback consistency test
- Equal weighting amplifies smaller buyback aristocrats that might be 0.1% of cap-weighted indices
- Natural quality tilt since only highly profitable companies can sustain 7+ years of meaningful buybacks
Risks
- Concentration risk with typically 20-40 holdings means single stock blowups hit 2.5-5% of the portfolio
- Buyback strategies underperform in bear markets when companies hoard cash instead of repurchasing shares
- Regulatory risk if Washington targets buybacks with taxes or restrictions, particularly hitting this concentrated strategy
Who Should Own This
Best for investors who view buybacks as a superior capital allocation signal and want concentrated exposure to management teams that walk the talk. Works as a 5-10% satellite holding to juice returns in a core equity allocation, particularly for those skeptical of dividend strategies in a rising rate environment. Not for anyone who needs broad diversification or gets nervous holding 30 stocks.